PD-L1 on host cells is essential for PD-L1 blockage-mediated tumor regression H Tang, Y Liang, RA Anders, JM Taube, X Qui, A Mulgaonkar, X Liu, ... The Journal of Clinical Investigation, 2018 | 482 | 2018 |
An Adipose Tissue Atlas: An Image-Guided Identification of Human-like BAT and Beige Depots in Rodents OKO Fang Zhang, Guiyang Hao, Mengle Shao, Kien Nham, Yu An, Qiong Wang, Yi ... Cell Metabolism 27 (1), 252-262, 2018 | 218 | 2018 |
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer J Kim, HM Lee, F Cai, B Ko, C Yang, EL Lieu, N Muhammad, S Rhyne, ... Nature metabolism 2 (12), 1401-1412, 2020 | 87 | 2020 |
PD-L1 detection using 89Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response J Vento, A Mulgaonkar, L Woolford, K Nham, A Christie, A Bagrodia, ... Journal for immunotherapy of cancer 7, 1-6, 2019 | 59 | 2019 |
PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers G Huang, T Zhao, C Wang, K Nham, Y Xiong, X Gao, Y Wang, G Hao, ... Nature biomedical engineering 4 (3), 314-324, 2020 | 46 | 2020 |
Tumor uptake of triazine dendrimers decorated with four, sixteen, and sixty-four PSMA-targeted ligands: Passive versus active tumor targeting J Lim, B Guan, K Nham, G Hao, X Sun, EE Simanek Biomolecules 9 (9), 421, 2019 | 17 | 2019 |
ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma A Mulgaonkar, R Elias, L Woolford, B Guan, K Nham, P Kapur, A Christie, ... Clinical Cancer Research 28 (22), 4907-4916, 2022 | 9 | 2022 |
Breast tumor micro-calcification induced by bone morphogenetic protein-2: a new murine model for human breast tumor diagnosis A Hajibeigi, K Nasr, D Udayakumar, K Nham, RE Lenkinski Contrast Media & Molecular Imaging, 2018 | 5 | 2018 |
Selective depletion of radiolabeled HER2-specific antibody for contrast improvement during PET P Khare, W Sun, S Ramakrishnan, R Swiercz, G Hao, ST Lo, K Nham, ... MAbs 13 (1), 1976705, 2021 | 2 | 2021 |
Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts E Butler, B Schwettmann, S Geboers, G Hao, J Kim, K Nham, X Sun, ... Pediatric Blood & Cancer 67 (12), e28639, 2020 | 2 | 2020 |
The hexosamine biosynthesis pathway is a targetable liability in lung cancers with concurrent KRAS and LKB1 mutations J Kim, F Cai, B Ko, C Yang, HM Lee, N Muhammad, K Li, M Haloul, W Gu, ... bioRxiv, 2020.04. 13.039669, 2020 | 1 | 2020 |
Design and Synthesis of a Novel Class of Theranostic Small-Molecule Drug Conjugates for Targeted Drug Delivery and Controlled Release S Debnath, G Hao, D Shryock, K Nham, H Hammers, X Sun Journal of Nuclear Medicine 60 (supplement 1), 1622-1622, 2019 | 1 | 2019 |
Chemically Identical Pair of Theranostic Small-Molecule Drug Conjugates for Prostate Cancer Imaging and Chemotherapy G Hao, B Guan, Y Wu, S Debnath, J Yang, Y Xiong, L Yang, K Nham, ... Nuclear Medicine and Biology 126, 108791, 2023 | | 2023 |
PD-L1 PET: A potential biomarker of checkpoint inhibitor sensitivity in renal cancer A Mulgaonkar, L Woolford, R Elias, K Nham, B Guan, G Hao, C Stevens, ... Cancer Research 82 (12_Supplement), 1234-1234, 2022 | | 2022 |
Immuno-PET Evaluation of In Vivo Therapeutic Resistance in Renal Cell Carcinoma Patient-Derived Xenografts S Manna, A Mulgaonkar, L Woolford, K Nham, G Hao, LM Pop, I Bowman, ... International Journal of Radiation Oncology, Biology, Physics 105 (1), E665, 2019 | | 2019 |
Immuno-PET imaging with 89Zr-atezolizumab in low and high PD-L1 expressing renal cell carcinoma patient-derived xenograft models G Hao, A Mulgaonkar, L Woolford, K Nham, B Guan, J Brugarolas, X Sun JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 62, S236-S237, 2019 | | 2019 |
Elevated PD-L1 Expression was Observed in Renal Cell Carcinoma by Immuno-PET after Stereotactic Ablative Body Radiation Treatment A Mulgaonkar, L Woolford, S Manna, K Nham, G Hao, R Hannan, ... Journal of Nuclear Medicine 60 (supplement 1), 1023-1023, 2019 | | 2019 |
Noninvasive Differentiation of Glioblastoma Multiforme (GBM) EGFR-Variants Using PET Imaging with 11C-Glutamine ST Lo, G Gao, K Nasr, K Nham, N Rydberg, A Habib, X Sun Journal of Nuclear Medicine 60 (supplement 1), 207-207, 2019 | | 2019 |
A practical workflow for statistical parametric mapping analysis of tau imaging in mice K Nham, J Yang, K Nsar, TL Thomas, J Vaquer-Alicea, MI Diamond, ... World Molecular Imaging Congress, 2018 | | 2018 |
Automated production of [1-11C] palmitate using commercial synthesizers G Hao, N Rydberg, R Hallgren, K Nham, X Sun Journal of Nuclear Medicine 59 (supplement 1), 1040-1040, 2018 | | 2018 |